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ABSTRACT
Objectives: This study investigated the antidiabetic and antihyperlipidemic potential of the ethanol extract of the leaves and stem of Cissus gracillis 
on alloxan monohydrate-induced diabetic albino rats.
Methods: Preliminary phytochemical screening and acute toxicity were carried out. Animals were assigned into seven groups of five rats each. 
Groups A and B were administered 10 mg/kg each of glibenclamide and atorvastatin respectively, C, D, and E were given 125, 250 and 500 mg/kg of 
ethanol extract of C. gracillis, respectively, daily for 21 days through oral gavage, group F was diabetic but untreated (diabetic control group), while 
group G was non-diabetic and untreated which served as the control group.
Results: Phytochemical screening revealed the presence of steroids/triterpenoids and carbohydrates. LD50 was above 5000 mg/kg. The extract at 
500 mg/kg showed a statistically significant (p<0.05) decrease in blood glucose level when compared with the glibenclamide group on day 21. 
However, gradual non- significant reduction in blood glucose levels were observed in the extract treated groups on the 7th, 14th, and 21st days of 
treatment. The administration of ethanol extract of C. gracillis to alloxan-induced diabetic rats produced a decrease in total cholesterol, triglycerides, 
and low-density lipoproteins comparable to glibenclamide and atorvastatin.
Conclusion: The ethanol extract of the leaves and stem of C. gracillis possess a mildly significant antidiabetic and antihyperlipidemic activity.
Keywords: Antidiabetic, Anti-hyperlipidaemic, Ethanol, Cissus gracillis, Alloxan, Glibenclamide, Atorvastatin.
INTRODUCTION
Diabetes mellitus is defined as a metabolic disorder characterized by a 
persistent elevation of blood glucose levels associated with absence or 
inadequate insulin secretion, with or without concurrent impairment of 
insulin action. Diabetes is usually classified according to the etiology, by 
far the most common two being type 1 and type 2 diabetes mellitus [1]. 
Diabetes is a global health problem and accounted for 1.5 million deaths 
in 2019 [2]. Several pathogenic processes are involved in the development 
of diabetes, ranging from autoimmune destruction of the β-cells of the 
pancreas with consequent insulin deficiency to abnormalities that result in 
resistance to insulin action. The basis of the abnormalities in carbohydrate, 
fat, and protein metabolism in diabetes is deficient action of insulin on 
target tissues. Impairment of insulin secretion and defects in insulin 
action frequently coexist in the same patient, and it is often unclear which 
abnormality, if either alone, is the primary cause of the hyperglycemia [3].
Besides hyperglycemia, other symptoms such as hyperlipidemia 
are involved in the development of microvascular complications of 
diabetes, which are the major causes of morbidity and death [4]. The 
World Health Organization has also substantiated the utilization of 
herbal remedies for the management of diabetes [5].
Management of diabetes without hyperlipidemia and various other 
associated side effects is still a challenge to the medicinal community. 
Combination of allopathic and herbal drugs may help to reduce 
the resistance to insulin and/or oral hypoglycemic therapy and the 
associated side effects. Hence, the continued research on medicinal 
plants which may serve as templates or leads for newer drugs.
Abnormalities in lipid profile are one of the most common 
complications in diabetes mellitus, which is found in about 40% of 
diabetes. The level of serum lipids (cholesterol, triglycerides, low-
density lipoprotein) is usually elevated in diabetes mellitus and 
such an elevation represents the risk factor for the development 
of coronary heart disease [6]. Cissus gracillis is an herbaceous, 
perennial climbing plant producing slender stem up to 7.5 m long. 
The stem crumbles over the ground, climbing into the surrounding 
vegetation and attaching themselves by the use of tendrils. The plant 
is sometimes harvested from the wild, mainly as a medicinal, but 
sometimes also as food [7]. It is known as Anaya or Yaakuwarfataakke 
(Hausa), Okwukwo-iri nwere-omughor (Ikwerre) in Nigeria [8]. 
However, some plants in the genus Cissus such as Cissus sycoidesis and 
Cissus quadrangularis have been reported to have antidiabetic and 
anti-hyperlipidaemic activity [9,10]. This present study examined the 
antidiabetic potential and the antihyperlipidaemic effects of ethanol 
extract of C. gracillis.
METHODS
Collection of plant materials
The plant C. gracillis was collected in Obelle Town, Emohua Local 
Government Area of Rivers State, Nigeria. Authentication was done 
by Dr. Ekeke Chimezie of the Department of Plant Science and 
Biotechnology, University of Port Harcourt with the herbarium number 
UPH/V/1249.
Plant extract preparation
The plant C. gracillis was collected, cleaned, shade dried for 2 weeks, 
and pulverized using a mechanical grinder. The plant powder (3.7 kg) 
was subjected to solvent extraction for 72 h with 17.84 L of absolute 
ethanol. The extract was concentrated using rotary evaporator and 
carefully evaporated to dryness over a water bath at 45°C while the 
dried extract was stored in a refrigerator.
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Animals used
A total of 47 healthy albino rats of average weight of 200 g was used. 
The animals were procured from the Department of Pharmacology, 
acclimatized, and fed with standard feeds (Top feed broiler finisher 
manufactured by Premier Feed Mills Company limited, Cross Rivers 
State, Nigeria) and water ad-libitum under hygienic condition.
Phytochemical screening test
Preliminary screening of the ethanol crude extract of C. gracillis was 
carried out to determine the presence of its constituents [11]. The 
intensity of the coloration and precipitates formed determined the 
abundance of the compound present.
Acute toxicological evaluation
The acute toxicity study of the plant extract was determined using 
modified [12] Lorke’s method with 18 healthy albino rats. The study 
was in two phases with 9 healthy albino rats each. In the first phase, 
the animals were randomly distributed to three groups of three animals 
each and treated with the ethanol extract of C. gracillis at doses of 10, 
100, and 1000 mg/kg orally. The animals were kept under observation 
for 24 h for signs of acute toxicity and death.
In the second phase, three groups of three healthy albino rats each were 
administered with the ethanol extract of C. gracillis at doses of 1600, 
2900, and 5000 mg/kg and were keenly observed for 24 h for signs of 
mortality and death.
Induction of diabetes mellitus
Diabetes was induced by intraperitoneal injection of alloxan 
monohydrate at a dose of 165 mg/kg body weight dissolved in cold 
normal saline. After a period of 72 h, the rats with fasting blood glucose 
levels >200 mg/dl were considered diabetic and thus selected for the 
study [13].
Evaluation of anti-diabetic and anti-hyperlipidaemic activity
The rats were allotted into seven groups of five rats each. Treatment 
was done daily for 21 days consecutively through oral gavage as 
outlined below:
1. Group A: Diabetic rats with glibenclamide (10 mg/kg)
2. Group B: Diabetic rats with atorvastatin (10 mg/kg)
3. Group C: Diabetic rats with C. gracillis extract (250 mg/kg)
4. Group D: Diabetic rats with C. gracillis extract (500 mg/kg)
5. Group E: Diabetic rats with C. gracillis extract (1000 mg/kg)
6. Group F: Diabetic untreated
7. Group G: Non-diabetic control.
Normal control and diabetic untreated animal groups received distilled 
water and standard feed. Body weights and the fasting blood glucose 
levels of all the animals were recorded at regular interval during the 
experimental period. Blood samples were collected from the tail tip of 
the animals on days 0, 7, 14, and 21, respectively. This was done with 
the aid of Accu-check glucometer test strips.
All the rats were sacrificed under anesthesia with diethyl ether at the 
end of the study and blood samples were analyzed for lipid profile 
parameters vis total cholesterol, triglycerides, high-density lipoprotein, 
and low-density lipoprotein at the Department of Chemical Pathology, 
the University of Port Harcourt with Randox kit (Randox lab. UK) and 
following the standard procedures as described by the manufacturers. 
The Low-density lipoprotein-cholesterol was calculated using 
Friedwald’s equation [14,15]. Ethics approval was obtained from 
the University of Port Harcourt research ethics committee with the 
reference number UPH/RandD/REC/04.
Statistical analysis
All the results obtained were analyzed using one-way analysis of 
variance followed by Student’s t-test with SPSS version 23. Comparison 
was done between treatment groups and control groups. p-values at 
p<0.05 were taken as significant.
RESULTS
Qualitative phytochemical screening
Qualitative phytochemical screening of the ethanol extract of the leaves 
and stem of C. gracillis revealed alkaloids, carbohydrates, cardenolides, 
and triterpenoids/steroids as its phytoconstituents while flavonoids, 
tannins, saponins, and anthraquinones were absent.
Acute toxicity
The result of the oral acute toxicity studies showed that the LD50 of 
the ethanol extract of C. gracillis was above 5000 mg/kg body weight. 
However, the main signs of acute toxicity observed was itching in the 
mouth which was highest with the dose of 5000 mg/kg.
Effect of the extract on blood glucose concentration
The extract at 500 mg/kg showed a statistically significant (p<0.05) 
decrease in blood glucose level when compared with the glibenclamide 
group on day 21 (Fig. 1).
Effect of the extract on lipid profile of albino rats
The extract at 125 mg/kg had a comparable total cholesterol value 
with the positive control group. The extract at 500 mg/kg exhibited 
a non-significant reduction in triglycerides level in comparison with 
the positive control and diabetic control groups. Treatment with the 
ethanol extract of C. gracillis showed a non-significant decrease in low-
density lipoproteins at 125 mg/kg when compared with the diabetic 
untreated group (Fig. 2).
DISCUSSION
Diabetes mellitus which is a chronic metabolic syndrome is associated 
with abnormally high blood glucose level as a result of insufficient 
secretion or resistance to insulin. This study evaluated the potential 
antidiabetic and anti-hyperlipidemic activities of ethanol extract of the 
leaves and stem of C. gracillis. At least a dozen plants from the genus 
Cissus have been used for treating various ailments in traditional 
medicines in different parts of the world. The qualitative phytochemical 
screening of the extract showed the presence of alkaloids, carbohydrates, 
triterpenoids, and cardenolides. This result can be related to studies done 
by Deokule and Waghmare [16], which showed that the phytochemical 
screening of C. quadrangularis and C. sycoidesis contained sterols/
triterpenoids, stilbens, iridoids, and had anti-diabetic and antilipidemic 
activities [17-19]. The oral acute toxicity of the ethanol extract of leaves 
and stems of C. gracillis showed only a mild itching in the mouth which 
was highest at the dose of 5000 mg/kg without any other adverse effect 
or mortality even at 5000 mg/kg, it could be said that the plant is very 
safe [12]. This result can be correlated to the report of Enechi [20], that 
the oral LD50 of the ethanol extract of the root of C. quadrangularis was 
greater than 5000 mg/kg.
Alloxan monohydrate causes enormous reduction in insulin release 
through the destruction of beta cells of the Islet of Langerhans, thereby 
inducing hyperglycemia [21]. In vitro studies have shown that alloxan 
monohydrate is selectively toxic to pancreatic beta cells causing cell 
necrosis. The cytotoxic action of alloxan monohydrate is mediated by 
the production of reactive oxygen species with resultant fragmentation 
of DNA of pancreatic cells [22]. In this study, the extract at 500 mg/kg 
showed a statistically significant (p<0.05) decrease in blood glucose 
level when compared with the glibenclamide group on day 21. However, 
gradual reduction in blood glucose levels was observed in the extract-
treated groups on the 7th, 14th and 21st days of treatment but could not 
considered to be significant. This result indicates a mild antidiabetic 
activity of the leaves and stem of C. gracillis. The mechanism by which 
C. gracillis may be eliciting its antidiabetic effect may be through the 
potentiation of pancreatic secretion of insulin from beta cells of islets 
of Langerhan or due to enhanced transportation and utilization of 
insulin in the peripheral tissues which can be corroborated with 
the reports of [23] on aqueous leaf extract of Millettia aboensis. The 
administration of ethanol extract of C. gracillis to alloxan-induced 
diabetic rats produced a decrease in total cholesterol, triglycerides, 
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and low-density lipoproteins which were comparable to glibenclamide 
and atorvastatin effects. This showed the protective effect of C. gracillis 
against the development of hyperlipidaemia. This can be related to the 
findings of [24] which stated that Mimosa pudica extract possessed 
anti-hyperlipidaemic effect. The antidiabetic and antihyperlipidaemic 
of C. gracillis may be attributed to the presence of alkaloids and 
triterpenoids as its phytoconstituents [25] while the absence of 
flavonoids and tannins in the extract may also be responsible for its 
inability to exhibit a pronounced antidiabetic activity [26].
CONCLUSION
The findings of this study have revealed that the ethanol extract of C. 
gracillis possess mild anti-diabetic activity and anti-hyperlipidaemic 
activity which may be due to the presence of alkaloids and triterpenoids 
as its biologically active constituents.
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Lipid profile  parameters
Glibenclamide (10 mg/kg) Atorvastatin (10 mg/kg)
Extract  (125 mg/kg) Extract (250 mg/kg)
Extract (500 mg/kg) Diabetic untreated
Non-diabetic
Fig. 2: Effect of Cissus gracillis on lipid profile of alloxan-induced 
diabetic rats, Values are represented as mean±SEM. TC: Total 
cholesterol, TG: Triglycerides, HDL: High density lipoprotein 
























Glibenclamide (10 mg/kg) Atorvastatin  (10 mg/kg) Extract  (125 mg/kg)
Extract (250 mg/kg) Extract (500 mg/kg) Diabetic untreated
Control group
 Fig. 1: Effect of Cissus gracillis on blood glucose concentrations of 
alloxan-induced diabetic rats
